Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

HSGX - Histogenics Corp.

Close
0.162
-0.072   -44.444%

Share volume: 29,541,386
Last Updated: Fri 27 Sep 2019 10:00:00 PM CEST
Biotechnology: -0.86%

PREVIOUS CLOSE
CHG
CHG%
$0.23
-0.07
-30.77%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
38%
Profitability 43%
Dept financing 43%
Liquidity 16%
Performance 37%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$0.16
P/E Ratio 
N/A
DAY RANGE
$0.15 - $0.21
EPS 
$0.19
52 WEEK RANGE
$0.08 - $1.43
52 WEEK CHANGE
-$71.48
MARKET CAP 
15.325 M
YIELD 
N/A
SHARES OUTSTANDING 
94.600 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$88,434,540
AVERAGE 10 VOLUME 
$12,040,021
AVERAGE 30 VOLUME 
$9,793,386
Company detail
CEO:
Region: US
Website: http://www.histogenics.com
Employees: 49
IPO year: -
Issue type: Common Stock
Market: NASDAQ
Industry: Biotechnology
Sector: Health Technology

Histogenics Corp. engages in the development, marketing, and commercialization of restorative cell therapies. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually and in concert to treat musculoskeletal-related conditions. The company was founded on June 28, 2000 and is headquartered in Waltham, MA.

Recent news